**Core Concept**
Verapamil, a calcium channel blocker, is a non-dihydropyridine agent that primarily affects the L-type calcium channels in the heart. It prolongs the atrioventricular (AV) node refractory period, which can lead to a decrease in heart rate and contractility. When used concurrently with beta blockers, which also affect the AV node, there is a risk of excessive depression of AV conduction, resulting in a conduction block.

**Why the Correct Answer is Right**
The combination of verapamil and beta blockers can lead to a significant decrease in AV node conduction velocity, potentially resulting in a complete heart block. This is because both classes of medications reduce the automaticity of the AV node and prolong its refractory period. Verapamil's primary effect on the L-type calcium channels in the AV node, coupled with beta blockers' effect on beta-1 receptors in the heart, can synergistically depress AV conduction, leading to a conduction block.

**Why Each Wrong Option is Incorrect**
**Option B:** Bronchospasm is a potential side effect of non-selective beta blockers, but it is not directly related to the combination of verapamil and beta blockers.

**Option C:** Neurogenic shock is a condition that can occur in response to trauma or other critical illnesses, and is not directly related to the pharmacological effects of verapamil and beta blockers.

**Option D:** Anaphylaxis is a severe, life-threatening allergic reaction that is not directly related to the combination of verapamil and beta blockers.

**Clinical Pearl / High-Yield Fact**
When combining calcium channel blockers with beta blockers, it is essential to monitor the patient's heart rate and rhythm closely, as excessive depression of AV conduction can occur. This is particularly important in patients with pre-existing conduction abnormalities or those at risk for heart block.

**✓ Correct Answer: A. Conduction block**